About Us

Biem is a biotechnology-focused pharmaceutical company founded in 1991 by Pharmacist Levent Canyurt established with domestic capital. The company began its journey by introducing innovative therapies to the Turkish pharmaceutical and healthcare market, quickly establishing a strong presence within the industry. Biem subsequently became the exclusive Turkish distributor for leading pharmaceutical companies based in the United States and Europe, with a particular focus on highly specialized therapeutic areas such as plasma-derived medicinal products. This foundation enabled the company to build a strong and reputable corporate position.

Today, Biem develops and manufactures products protected by intellectual property rights through a local manufacturing infrastructure that fully complies with global regulatory and licensing requirements. Supported by a strong R&D organization and an advanced manufacturing facility, the company manages the highly specialized processes required for biological pharmaceuticals within integrated quality management systems.

Biem operates across a broad range of specialized therapeutic areas, including oncology, hematology, radiology, ophthalmology, neurology, intensive care, nephrology, gastroenterology, and transplantation. Backed by decades of experience, internationally aligned quality standards, and robust scientific and operational capabilities, Biem has established itself as a respected and trusted partner in the pharmaceutical industry.